Latigo Biotherapeutics, Inc. (LTGO)
21.08
-1.47
(-6.52%)
USD |
NASDAQ |
Sep 21, 16:00
20.70
-0.38
(-1.80%)
After-Hours: 20:00
Latigo Biotherapeutics Total Liabilities (Quarterly) : 52.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.26M |
| Date | Value |
|---|---|
| March 31, 2026 | 14.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.76M |
| Shareholders Equity (Quarterly) | 12.50M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 1.148 |